Table: Cosmos Pharmaceutical - 6-MTH group results

Cosmos Pharmaceutical

10/01/2025 06:30

Jan 10 (Reuters)- 
             Cosmos Pharmaceutical Corp. 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 6 months ended      6 months ended       Year to 
                Nov 30, 2024        Nov 30, 2023     May 31, 2025 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales            505.94              476.43          1.04 trln  
                 (+6.2 pct)          (+17.9 pct)      (+7.5 pct)  
  Operating         20.34               15.84            31.60    
                 (+28.5 pct)         (+2.9 pct)       (+0.3 pct)  
  Recurring         21.78               17.35            34.40    
                 (+25.5 pct)         (+2.6 pct)       (+0.3 pct)  
  Net               14.43               11.59            24.50    
                 (+24.5 pct)         (+2.6 pct)       (+0.2 pct)  
  EPS            182.05 yen          146.27 yen       309.12 yen  
  Ann Div                            120.00 yen        65.00 yen  
  -Q2 div         32.50 yen           60.00 yen                   
  -Q4 div                             60.00 yen        32.50 yen  
  
  NOTE - Cosmos Pharmaceutical Corp.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=3349.T